High IL‐6 levels and activation of IL‐6:STAT3 signaling has been reported to induce a cancer stem cell phenotype to nonstem cells 28, while IL‐6 trans‐signaling (through IL‐6:IL‐6R) has itself been implicated in 4T1 metastasis 20. Here, IL6R is linked to cancer.